@article{ART003300536},
author={Yeonhee Seo},
title={A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT)},
journal={CELLMED},
issn={3022-6805},
year={2026},
volume={16},
number={1},
pages={3-3},
doi={10.5667/CellMed.spc.154}
TY - JOUR
AU - Yeonhee Seo
TI - A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT)
JO - CELLMED
PY - 2026
VL - 16
IS - 1
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 3
EP - 3
SN - 3022-6805
AB - Objective: Atopic dermatitis is a chronic, relapsing inflammatory dermatosis characterized by intense pruritus, xerosis, erythema, oozing, and lichenification. Its pathogenesis is primarily attributed to epidermal barrier dysfunction and dysregulated immune responses, with environmental exposures and lifestyle factors further contributing to disease exacerbation. Standard management focuses on regular moisturization, barrier repair, and topical therapies, whereas phototherapy or systemic therapies may be considered for patients with inadequate disease control. However, therapeutic responses and patterns of relapse vary substantially among individuals, indicating the need for a personalized treatment approach that reflects patient-specific characteristics.
Case Report: The patient in this case was a Korean male in his 20s with a history of recurrent exacerbations and remissions of atopic dermatitis since infancy. Despite ongoing treatment with oral medications and topical therapies, his symptoms recurred intermittently. In adulthood, both the extent and severity of the lesions increased, making adequate disease control more difficult with conventional therapy alone. Therefore, Ortho-Cellular Nutrition Therapy (OCNT) was introduced to protect the skin barrier and improve clinical symptoms. As a result, the patient achieved a clinically meaningful improvement and has maintained a stable condition without major relapse to date.
Conclusion: However, this report describes a single-patient case and is therefore limited in its ability to generalize the findings or to apply the same OCNT protocol to all patients with atopic dermatitis. Nevertheless, the findings suggest that appropriately prescribed, individualized OCNT tailored to a patient’s symptom patterns and overall health status may be associated with improvement of atopic dermatitis symptoms.
KW - Ortho-Cellular Nutrition Therapy (OCNT);Atopic dermatitis;Inflammatory response;Skin hydration;Immunity
DO - 10.5667/CellMed.spc.154
ER -
Yeonhee Seo. (2026). A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT). CELLMED, 16(1), 3-3.
Yeonhee Seo. 2026, "A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT)", CELLMED, vol.16, no.1 pp.3-3. Available from: doi:10.5667/CellMed.spc.154
Yeonhee Seo "A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 16.1 pp.3-3 (2026) : 3.
Yeonhee Seo. A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT). 2026; 16(1), 3-3. Available from: doi:10.5667/CellMed.spc.154
Yeonhee Seo. "A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 16, no.1 (2026) : 3-3.doi: 10.5667/CellMed.spc.154
Yeonhee Seo. A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT). CELLMED, 16(1), 3-3. doi: 10.5667/CellMed.spc.154
Yeonhee Seo. A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT). CELLMED. 2026; 16(1) 3-3. doi: 10.5667/CellMed.spc.154
Yeonhee Seo. A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT). 2026; 16(1), 3-3. Available from: doi:10.5667/CellMed.spc.154
Yeonhee Seo. "A Case Report on the Improvement of Atopic Dermatitis Symptoms Using Ortho-Cellular Nutrition Therapy (OCNT)" CELLMED 16, no.1 (2026) : 3-3.doi: 10.5667/CellMed.spc.154